NCT01937559View on ClinicalTrials.gov

Topical Tranexamic Acid (TXA) in Joint Arthroplasty

PHASE4CompletedINTERVENTIONAL
Enrollment

188

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

June 30, 2018

Study Completion Date

November 30, 2018

Conditions
OsteoarthritisHip ArthropathyShoulder Arthropathy
Interventions
BIOLOGICAL

Tranexamic acid (TXA)

1.5g of TXA in 100ml normal saline solution

DRUG

Normal saline

Trial Locations (1)

29615

Steadman Hawkins Clinic of the Carolinas - Greenville Health System, Greenville

All Listed Sponsors
lead

The Hawkins Foundation

OTHER

NCT01937559 - Topical Tranexamic Acid (TXA) in Joint Arthroplasty | Biotech Hunter | Biotech Hunter